AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TOFACITINIB
10 registrations across 5 African markets— 7 active
Markets with TOFACITINIB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TOFADOZ 5 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Nov 2030 |
| TOFADOZ 10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Nov 2030 |
| Jitrit-5 Tablet | 🇰🇪Kenya | Micro Labs Limited | active | Aug 2030 |
| TOFADOZ 5 Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | Jul 2030 |
| Xeljanz 5 mg Tablets** Tablet | 🇳🇬Nigeria | Pfizer Specialties Ltd | active | Jan 2028 |
| JITRIT-5 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MICRO LABS LIMITED | active | Dec 2027 |
| XELJANZ TABLET; ORAL | 🇿🇼Zimbabwe | PFIZER LABORATORIES (PTY) LTD, S.A | active | Dec 2027 |
| XELTIN 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| TOFACITINIB NEAPOLIS Comprimé pelliculé / 5 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Jun 2022 |
| XELJANZ Comprimé pelliculé / 5 mg | 🇹🇳Tunisia | PF PRISM C.V C/O PFIZER NETHERLANDS | expired | Nov 2018 |
TOFACITINIB in Africa — Regulatory Overview
TOFACITINIB is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Kenya, Tunisia, Malawi and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 7 (70%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.